Abstract. The full-length Blo t 11 allergen was expressed as a GST-fusion protein in E. coli by IPTG induction and purified by affinity chromatography using an Agarose-Glutathione column. Fractions containing recombinant Blo t 11, resolved as 128 kD protein, were pooled and quantified using the BioRad Protein Assay. Native Blo t 11 was purified from a Blomia tropicalis (Bt) aqueous extract using a Blo t 11 monoclonal antibody affinity column. Two milliliters of the Bt extract yielded 467 ng of native Blo t 11 which was resolved as ~60 kD in an SDS-PAGE. The immunoglobulin E binding activity of the purified allergens was determined by enzyme-linked immunosorbent assay using a panel of 110 atopic Filipino patients' sera and 85 non-atopic sera. The native Blo t 11 allergen registered an IgE reactivity of 63% (69/110) while the recombinant Blo t 11 registered 57% (63/110). The Blo t 11 allergen can inhibit up to 63% IgE binding activity of Bt aqueous extract. Results presented herein demonstrate the clinical importance of Blo t 11 allergen as a triggering factor for allergies among Filipino atopic patients thus a potential reagent for diagnosis and immunotherapy of house dust mite allergy in the local setting.
INTRODUCTION INTRODUCTION INTRODUCTION INTRODUCTION INTRODUCTION
Immediate hypersensitivity reactions to substances in the environment can cause a number of common allergic diseases including allergic asthma, allergic rhinitis, and atopic dermatitis. Allergies are chronic inflammatory diseases, with periods of remission and flare-ups that adversely affects the quality of life of patients and their families. Epidemiological studies show that Blo t 11 is a 2625 bp paramyosin homolog allergen gene isolated from Blomia tropicalis (Bt) [4] , an HDM species ubiquitously found in tropical and subtropical regions [5] . Allergens isolated from Bt exhibit significant immunoglobulin E (IgE)-binding activities demonstrating the clinical importance of this HDM species as an important source of major allergens that trigger allergic reactions among atopic individuals [6] . Recombinant and native Blo t 11 exhibits IgE reactivity in more than 50% of Singaporean and Malaysian allergic patients' sera tested [7] [8] [9] but its clinical importance has never been shown among Filipino allergic patients. The IgE-binding activity of the recombinant and native Blo t 11 allergen among Filipino allergic patients is comparatively shown in this study. Expression and Purification of rBlo t 11. The recombinant Blo t 11 allergen was produced as previously described [4] . In brief, a clone of E. coli (BL21) containing the Blo t 11 gene in pGEX-4T-1 vector was cultured in LB broth with Ampicillin. The allergen was expressed as a glutathione S-transferase (GST) fusion protein by isopropyl-β-Dthiogalactopyranoside (IPTG) induction. Purification of recombinant proteins was performed by affinity chromatography using a Glutathione-Agarose column (Sigma, USA) according to the protocol described in the GST Purification Module (Pharmacia Biotech, UK). Purified protein sample was quantified by the BioRad Protein Assay (BioRad, USA), and was analyzed by SDS-PAGE.
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HDM Aqueous Extract Preparations.
Ten grams (wet weight) of frozen Bt was wrapped in aluminum foil and stored in a -80°C for 20 minutes. The frozen mites were mechanically ground using a precooled mortar and pestle for 30 minutes. Extraction was performed using a total volume of 50 mL of 1X TBS with 2 mM PMSF (Sigma-Aldrich, Saint Louis, MO, USA) and 1 mM EDTA (BioRad, Hercules, CA, USA) added slowly while grinding the mites. The mite extract suspension was incubated for 16-20 hours at 4°C with constant shaking. After centrifugation at 17,000 rpm for 20 minutes using the Sorvall R Ultra Pro 80 centrifuge (Kendro Lab. Products, Newtown, CT, USA), the supernatant was collected and quantified by BioRad Protein Assay as described below. Aqueous Bt protein extracts were stored in aliquots at -80°C until use.
Isolation of Native Blo t 11. Purification of the native Blo t 11 allergen from an aqueous Bt extract was performed using an immuno-affinity column chromatography as previous described [10] . Briefly, a column of Sepharose beads coupled with P2E7-G1 Blo t 11 monoclonal antibody was thoroughly washed with 1x TBS until the OD at 280 nm was 0. A 500 mg Bt aqueous extract was then gently passed through the column followed by another wash as described. Bound nBlo t 11 was eluted in 1.0 mL fractions using 5 mM Glycine, 50% Ethylene Glycol (Merck, Darmstadt, Germany), pH 11. Six hundred mL of each fraction were precipitated using trichloroacetic acid, TCA, (Merck, Darmstadt, Germany) and analyzed by denaturing SDS-PAGE followed by silver staining. Fractions with native Blo t 11 were pooled and quantified using the BioRad Protein Assay as described below. 
Recombinant and Native Blo t 11.
Recombinant Blo t 11 allergen was expressed as a GST-fusion protein in E. coli by IPTG induction for three hours. A two-liter culture of E. coli containing the Blo t 11-pGEX-4T-1 vector was prepared, cells collected by centrifugation and lysed using SDS Lysis buffer. A total of 0.7 mg rBlo t 11 per liter of E. coli culture was isolated by affinity chromatography using a Glutathion-Agarose column. The purified rBlo t 11-GST allergen migrated at 128 kDa on an SDS-PAGE gel ( Figure 1a ) in line with its predicted molecular weight (102 kDa + 26 kDa GST).
The purified rBlo t 11 reacted positively to the Blo t 11 monoclonal antibody P2E7-G1 (Figure 1c ) confirming the identity of the purified allergen. No reactivity was observed with the GST. Low yield of insoluble recombinant Blo t 11-GST fusion protein were obtained as previously reported [4] . The relatively large size of the recombinant protein might have contributed to the observed low expression. Furthermore, the recombinant protein was highly susceptible to degradation and the GST failed to be cleaved off after thrombin digestion. The susceptibility of a paramyosin homolog protein was likewise reported in both the native and recombinant Der f 11 expressed in E. coli [11] and in E. coli-expressed Sarcoptes scabei paramyosin [12] . Expression of recombinant protein in E. coli has been a successful and convenient method for the production of large amounts of many HDM allergens. Recombinant allergens expressed in E. coli as fusion proteins offer the advantages of ease of manipulation, short time of expression, ease in obtaining large quantities of recombinant proteins, and the availability of fast and efficient purification systems.
Native Blo t 11 was purified from a Bt aqueous extract using a Blo t 11 monoclonal antibody affinity column. Two milliliters of Figure 1 . SDS-PAGE profile of the recombinant Blo 11-GST (a) and native Blo t 11 (b). Western Blot analysis of the purified Blo t 11 allergens using monoclonal antibody P2E7-G1 (c).
the Bt extract yielded 467 ng of native Blo t 11. The purified nBlo t 11 was partially degraded; the major derived peptide was approximately 60 kD ( Figure 1b) . Similarly to the recombinant Blo t 11, the purified native allergen reacted positively to monoclonal antibody P2E7-G1 (Figure 1c) . The results presented herein are consisted with previous studies showing the isolation of a native paramyosin with a molecular weight of -60 kDa [10] . The presence of high molecular weight allergens in B. tropicalis was first observed in the results of crossed radioimmuno-electrophoresis (CRIE) studies [13] and immunoblotting experiments [14] using the whole Bt extract, which revealed the presence of multiple species-specific IgEbinding antigens with molecular weights ranging from 11-85 kD. It is possible that some of the high molecular weight antigens previously identified in the whole Bt extract are the degradation products of the nBlo t 11.
The IgE-binding capacity of the recombinant and native Blo t 11 allergens were determined by ELISA using a panel of sera from 110 Filipino Bt-allergic subjects and 85 Filipino non-allergic subjects. A relatively low IgE concentration of the 85 non-allergic sera against the native and recombinant Blo t 11 allergens and GST was detected ( Figure 2) . None of the non-allergic sera used in this study registered an allergen-specific IgE concentration above 100 ng/mL. The mean + the standard deviation of the IgE concentration observed among the 85 non-allergic sera was used as a cut-off value in determining positive reactions among the allergic sera used in this study.
Results of the IgE ELISA using the panel of sera from 110 Bt-allergic subjects showed that the native Blo t 11 allergen registered an IgE reactivity of 63% (69/110) while the recombinant Blo t 11 registered 57% (63/110) ( Figure 3 ). The IgE-binding capacity of the recombinant Blo t 11 was comparable to that of the purified nBlo t 11 although a slightly lower percentage of IgE reactivity was observed with the recombinant allergen. As previously reported, it is not unusual for the biological activity of a recombinant protein produced in E. coli to exhibit lower IgE reactivity compared to the native protein [15] [16] . To further validate the importance of Blo t 11 as a major component of Bt aqueous extract as a sensitizing agent for allergic reactions, inhibition assay was performed. The Blo t 11 allergens can inhibit up to 63% IgE binding activity of Bt aqueous extract (Figure 4 ). Using five sera that reacted positively to the three allergens used, 40.8%, 44.4% and 9.8% mean inhibition was observed with the recombinant Blo t 11, native Blo t 11 and GST, respectively, against the IgE reactivity of the Bt aqueous extract. The comparable inhibition capacity of the recombinant and the native Blo t 11 allergens against the IgE reactivity of the Bt aqueous extract further supports the presence of similar IgE binding capacity of the forms of the allergen. Considering the comparable IgE-binding capacity of the recombinant Blo t 11 to its native counterpart, the recombinant Blo t 11 is good candidate substitute reagent for HDM allergy diagnosis and immunotherapy. Added to this, recombinant Blo t 11 yields higher allergen concentration compared to 
